Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-13

Clinical Trial Update: Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Norfloxacin with Itopride versus Norfloxacin alone for secondary prophylaxis of spontaneous bacterial peritonitis is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norfloxacin (Norfloxacin)
  • Norfloxacin with Itopride

Snippet

Sponsor: Tanta University | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: RECRUITING